**Question:** Which of the following is false about Behcet's Syndrome

A. Behcet's Syndrome is a rare disorder affecting the blood vessels and immune system.
B. The syndrome is named after Hulusi Behçet, a Turkish physician who first described the condition in 1937.
C. Behcet's Syndrome primarily affects the digestive tract and liver.
D. Treatment options for Behcet's Syndrome include surgical intervention in most cases.

**Core Concept:** Behçet's Syndrome is a chronic inflammatory disorder characterized by recurrent oral, genital, and ocular ulcers, as well as skin lesions, arthritis, and potentially, vasculitis affecting blood vessels of various sizes. The syndrome is named after Turkish physician Hulusi Behçet, who first described the condition in 1937.

**Why the Correct Answer is Right:** Behçet's Syndrome primarily affects small and medium-sized blood vessels, and its symptoms involve vasculitis, inflammation of blood vessels. In contrast, option C states that Behçet's Syndrome primarily affects the digestive tract and liver, which is incorrect as the syndrome primarily involves blood vessels.

**Why Each Wrong Option is Incorrect:**

**Option A:** While Behçet's Syndrome is a rare disorder, it does not predominantly affect blood vessels and immune system. This option incorrectly focuses on the rarity of the syndrome, rather than its primary vascular involvement.

**Option B:** While Behçet's Syndrome was named after Hulusi Behçet, it does not primarily affect the liver and digestive tract. This option incorrectly highlights the involvement of the liver and digestive tract, rather than the primary vascular involvement of the syndrome.

**Option D:** Treatment of Behçet's Syndrome often involves pharmacological interventions, not surgical intervention in most cases. This option incorrectly emphasizes surgical intervention, which is rarely the primary treatment approach for Behçet's Syndrome.

**Clinical Pearl:** Behçet's Syndrome is a complex, multi-system disorder that primarily affects the vasculature, including small and medium-sized blood vessels. Treatment options typically involve immunosuppressive and immunosuppressive agents, not surgical intervention.